Clearside Biomedical (NASDAQ:CLSD) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Clearside Biomedical missed estimated earnings by 62.5%, reporting an EPS of $-0.13 versus an estimate of $-0.08.
Revenue was up $313.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.15 which was followed by a 42.59% increase in the share price the next day.
Here’s a look at Clearside Biomedical’s past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.16 | -0.08 | -0.12 | -0.10 |
| EPS Actual | 0.31 | -0.08 | -0.11 | -0.13 |
| Revenue Estimate | 17.77M | 2.58M | 690.00K | 2.12M |
| Revenue Actual | 25.69M | 3.07M | 780.00K | 34.00K |
To track all earnings releases for Clearside Biomedical visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
